ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,521Medicare Part D Prescriptions Filled, Including Refills

Rank: 391 out of 2588

$446K Total Retail Price of All Prescriptions

Rank: 564 out of 2588

260 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 260 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 455 404 1 4
LEVOTHYROXINE SODIUM 399 317 2 2
METOPROLOL SUCCINATE 385 357 3 12
LISINOPRIL 309 266 4 3
FUROSEMIDE 294 265 5 5
CRESTOR 289 259 6 25
NORTRIPTYLINE HCL 278 226 7 237
TRIAMTERENE-HCTZ 253 241 8 46
ATORVASTATIN CALCIUM 249 219 9 11
LOSARTAN POTASSIUM 248 241 10 17
POTASSIUM CHLORIDE 246 214 11 15
WARFARIN SODIUM 223 192 12 10
METOPROLOL TARTRATE 219 194 13 9
SIMVASTATIN 217 183 14 1
HYDROCHLOROTHIAZIDE 193 180 15 13
METFORMIN HCL ER 186 152 16 67
OMEPRAZOLE 182 168 17 6
HYDROCODONE-ACETAMINOPHEN 167 148 S3 18 7
SERTRALINE HCL 153 115 19 26
CARVEDILOL 150 137 20 20
GLIPIZIDE 139 139 21 44
PAROXETINE HCL 134 120 22 71
PRAVASTATIN SODIUM 111 107 23 16
ZETIA 107 107 24 69
BENICAR 101 88 25 143
JANUVIA 93 87 26 60
CLOPIDOGREL 86 64 27 30
CYMBALTA 82 58 28 70
KLOR-CON M20 79 67 29 52
MELOXICAM 73 56 30 51
HUMULIN N 71 56 31 318
ATENOLOL 70 64 32 14
ESCITALOPRAM OXALATE 70 65 32 68
NEXIUM 69 32 34 41
FLUOXETINE HCL 63 36 35 92
FINASTERIDE 62 62 36 97
FLUTICASONE PROPIONATE 61 52 37 40
SYNTHROID 60 59 38 88
INSULIN SYRINGE 58 38 39 81
AMITRIPTYLINE HCL 56 56 R 40 91
NAMENDA 53 53 41 32
BENAZEPRIL HCL 52 52 42 84
LIPITOR 51 40 43 114
CITALOPRAM HBR 50 36 44 27
DONEPEZIL HCL 50 50 44 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.